- Home
- PDSB vs KRON Comparison
PDSB vs KRON Comparison
Compare PDSB & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- KRON
- Stock Information
- Founded
- PDSB 2005
- KRON 2017
- Country
- PDSB United States
- KRON United States
- Employees
- PDSB N/A
- KRON N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- KRON Medicinal Chemicals and Botanical Products
- Sector
- PDSB Health Care
- KRON Health Care
- Exchange
- PDSB Nasdaq
- KRON Nasdaq
- Market Cap
- PDSB 58.7M
- KRON 61.5M
- IPO Year
- PDSB N/A
- KRON 2020
- Fundamental
- Price
- PDSB $1.34
- KRON $1.00
- Analyst Decision
- PDSB Strong Buy
- KRON Buy
- Analyst Count
- PDSB 3
- KRON 3
- Target Price
- PDSB $14.00
- KRON $1.63
- AVG Volume (30 Days)
- PDSB 235.1K
- KRON 223.2K
- Earning Date
- PDSB 03-26-2025
- KRON 03-20-2025
- Dividend Yield
- PDSB N/A
- KRON N/A
- EPS Growth
- PDSB N/A
- KRON N/A
- EPS
- PDSB N/A
- KRON N/A
- Revenue
- PDSB N/A
- KRON $9,864,000.00
- Revenue This Year
- PDSB N/A
- KRON $62.21
- Revenue Next Year
- PDSB N/A
- KRON N/A
- P/E Ratio
- PDSB N/A
- KRON N/A
- Revenue Growth
- PDSB N/A
- KRON 146.48
- 52 Week Low
- PDSB $1.25
- KRON $0.69
- 52 Week High
- PDSB $6.68
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- PDSB 40.27
- KRON 50.71
- Support Level
- PDSB $1.41
- KRON $0.97
- Resistance Level
- PDSB $1.56
- KRON $1.03
- Average True Range (ATR)
- PDSB 0.14
- KRON 0.05
- MACD
- PDSB -0.00
- KRON 0.00
- Stochastic Oscillator
- PDSB 21.24
- KRON 65.52
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.